Work

A phase I/II multisite study of rucaparib and pembrolizumab maintenance therapy in stage IV non-squamous non–small cell lung cancer after initial therapy with carboplatin, pemetrexed, and pembrolizumab.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.tps9138

Authors: Angel Qin, Daniel Morgensztern, Saiama Naheed Waqar, Dwight Hall Owen, Shirish M. Gadgeel, Gregory Peter Kalemkerian, Lili Zhao, Nithya Ramnath

Institutions: University of Michigan, U-M Rogel Cancer Center, Washington University in St. Louis, The Ohio State University, Henry Ford Health, Henry Ford Hospital, VA Ann Arbor Healthcare System, Ann Arbor VA Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281688807

Cites:

Cited by:

Related to: 10